EMA Opinion Bodes Well for Biopharma’s Drug Getting Orphan Status

 

EMA Opinion Bodes Well for Biopharma’s Drug Getting Orphan Status

Shares of Anavex Life Sciences Corp. may be subject to the Securities and Exchange Commission’s Penny Stock Rules, which may set forth sales practice requirements for certain low-priced securities. …

More EMA Opinion Bodes Well for Biopharma’s Drug Getting Orphan Status Videos

Leave a Reply